Bluejay Diagnostics, Inc.
NASDAQ: BJDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Indranil Dey
- Employees
- 7
- Headquarters
- Acton, United States
- IPO year
- 2021
- Market cap
- $1.4M
- Website
- https://bluejaydx.com
Loading BJDX…
Loading profile data…Frequently asked questions about BJDX
What does Bluejay Diagnostics, Inc. (BJDX) do?
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassa...
Where does BJDX trade?
Bluejay Diagnostics, Inc. (BJDX) trades on the NASDAQ Capital Market.
What sector is BJDX in?
Bluejay Diagnostics, Inc. (BJDX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Bluejay Diagnostics, Inc.?
Indranil Dey is the chief executive officer of Bluejay Diagnostics, Inc. (BJDX).
Where is Bluejay Diagnostics, Inc. headquartered?
Bluejay Diagnostics, Inc. is headquartered in United States.
Does BJDX pay a dividend?
Bluejay Diagnostics, Inc. (BJDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BJDX go public?
Bluejay Diagnostics, Inc. (BJDX) completed its initial public offering in 2021.